Response to Mitchell D. Creinin's letter regarding "extended use of the intrauterine device: A literature review and recommendations for clinical practice"

Contraception

Volumn 90, Issue 6, 2014, Pages 621-622

  Wu, Justine ^a   Pickle, Sarah ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRIER CONTRACEPTION; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONTRACEPTIVE BEHAVIOR; COPPER INTRAUTERINE DEVICE; DEVICE APPROVAL; DEVICE SAFETY; FEMALE; FOLLOW UP; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LETTER; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; PATIENT RISK; UNPLANNED PREGNANCY; ADVERSE EFFECTS; EVIDENCE BASED MEDICINE; PACKAGING; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PREGNANCY; WOMEN'S HEALTH;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; INTRAUTERINE DEVICES; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRODUCT LABELING; WOMEN'S HEALTH;

EID: 84911391815     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2014.05.016     Document Type: Letter

References (3)

1. J.P. Wu, and S. Pickle Extended use of the intrauterine device: a literature review and recommendations for clinical practice Contraception 89 6 2014 495 503
2. M. Ronnerdag, and V. Odlind Health effects of long-term use of the intrauterine evonorgestrel releasing system. A follow-up study over 12years of continuous use Acta Obstet Gynecol Scand 78 8 1999 716 721
3. M.M. Hidalgo, C. Hidalgo-Regina, and M.V. Bahamondes Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system Contraception 80 1 2009 84 89